NCT01463605View on ClinicalTrials.gov

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

February 29, 2020

Conditions
Esophageal Cancer
Interventions
DRUG

Nimotuzumab

Nimotuzumab 200mg,once per week,for 5 to 6 weeks

Trial Locations (1)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT01463605 - Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial | Biotech Hunter | Biotech Hunter